Business
Media
Conferences
Publications
CME/CE
Resources
Subscribe

Treatment Options in Metastatic Castration-Resistant Prostate Cancer: A Year In Review

EP. 1: Overview of Metastatic Castration-Resistant Prostate Cancer

ByUrology Times staff

December 20th 2020

EP. 2: Genetic Testing in Metastatic Castration-Resistant Prostate Cancer

ByUrology Times staff

December 20th 2020

EP. 3: Genetic Testing: A Conversation with Your Patient

ByUrology Times staff

December 20th 2020

EP. 4: Newly Approved Agents for Metastatic Castration-Resistant Prostate Cancer

ByUrology Times staff

December 20th 2020

EP. 5: A Look at the PROfound Trial

ByUrology Times staff

December 20th 2020

EP. 6: The Role of PARP Inhibitors in Prostate Cancer

ByUrology Times staff

December 20th 2020

EP. 7: COVID-19 and Treating Metastatic Castration-Resistant Prostate Cancer

ByUrology Times staff

December 20th 2020

Trending on Urology Times

FDA approves Titan Prime Inflatable Penile Prosthesis

Phase 1 AcTION trial establishes RP2D for 225Ac-PSMA-617

FDA updates in urology: May 2026

FDA approves cefepime and zidebactam for complicated UTI

PROTEUS: Apalutamide plus ADT before and after RP cuts metastasis risk